Skip to main content
. 2010 Oct-Dec;2(4):356–361. doi: 10.4103/0975-1483.71623

Table 3.

Comparative ex-in vitro dissolution profile of different formulations

Time (h) Percentage amount of drug release
Pure drug solution Formulation
NF1 NF2 NF3 LF1 LF2 LF3
1 67.56±1.60 07.89 ± 0.99 06.37 ± 0.99 12.89 ± 0.99 6.81±0.89 7.89 ± 0.99 05.37 ± 0.93
2 78.31±1.10 13.04 ± 0.98 13.12 ± 0.98 15.68 ± 0.98 12.12 ± 0.45 13.04 ± 0.98 11.13 ± 0.93
3 78.80±1.40 13.36 ± 0.99 14.31 ± 1.09 18.92 ± 0.97 13.17 ± 0.67 13.36 ± 0.99 13.21 ± 1.10
4 78.98±1.30 14.00 ± 0.98 15.87 ± 1.17 24.76 ± 0.94 13.98 ± 0.28 14.00 ± 0.98 14.87 ± 0.98
5 80.00±1.30 15.64 ± 0.97 16.59 ± 0.99 27.56 ± 0.99 14.69 ± 0.57 15.64 ± 0.97 15.52 ± 0.56
6 80.64±1.25 17.56 ± 0.99 18.57 ± 0.98 27.89 ± 0.98 16.34 ± 0.78 17.56 ± 0.99 17.53 ± 0.98
7 81.74±1.80 17.76 ± 1.05 20.55 ± 0.99 28.56 ± 0.99 17.26 ± 0.98 17.76 ± 1.00 19.38 ± 0.78
8 83.12±1.30 18.89 ± 1.10 22.56 ± 0.98 29.81 ± 1.07 18.39 ± 1.05 18.89 ± 1.10 21.54 ± 0.98